期刊文献+

GRP94蛋白的生物学特性及其与肿瘤的关系研究进展

Research Progress on Biological Characteristics of GRP94 Protein and its Relationship with Tumors
原文传递
导出
摘要 葡萄糖调节蛋白94(GRP94)有多种其他生物学的功能,并与热休克蛋白90之间具有同源性。GRP94参与抗原受体的装备和抗原的加工和提呈,能促进DC成熟活化,在细胞凋亡和免疫应答中有重要的作用。GRP94的表达水平与肿瘤发展情况相关,并参与肿瘤免疫应答过程,肿瘤组织来源的GRP94结合有肿瘤特异性抗原多肽,能够诱导特异性抗肿瘤免疫,在肿瘤发生和进展之中也发挥着重大的作用。目前研究得到证实,GRP94-肽复合物疫苗对多种癌症早中期能起到保护性免疫的作用,应用GRP94-肽复合物疫苗治疗癌症的前景十分广阔。但GRP94-肽复合物疫苗对晚期肿瘤疗效不明确,还需进行大量临床研究。 Glucose regulatory protein 94(GRP94)has many biological functions and homology with heat shock protein 90.GRP94 participates in the equipment of antigen receptor and the processing and presentation of antigen,promotes the maturation and activation of DC,and plays an important role in apoptosis and immune response.The expression level of GRP94 is related to the development of tumors and participates in the process of immune response.GRP94 from tumors can induce specific anti-tumor immunity by binding with tumor-specific antigen polypeptide,which also plays an important role in tumorigenesis and progression.Current studies have confirmed that GRP94-peptide complex vaccine can play a protective immune role in the early and middle stages of various cancers,and the application of GRP94-peptide complex vaccine in cancer treatment has broad prospects.However,the efficacy of GRP94-peptide complex vaccine for advanced tumors is not clear,and a large number of further clinical studies are needed.
作者 邓晓杨 朱晓莺 杨昕蕾 邓洁 徐蕾 DENG Xiao-yang;ZHU Xiao-ying;YANG Xin-Lei;DENG Jie;XU Lei(Department of Gynecology,Lhasa Sunshine Maternity Hospital,Lhasa 850000,China;School of Clinical Medicine,Ningxia Medical University,Yinchuan 750004,China;The First Affiliated Hospital of Chengdu Medical College,Chengdu 610500,China)
出处 《药物生物技术》 CAS 2020年第5期486-489,共4页 Pharmaceutical Biotechnology
基金 四川省教育厅自然科学重点项目(No.17ZA0128)
关键词 GRP94蛋白 生物学特性 肿瘤 研究进展 细胞 凋亡 疗效 热休克蛋白 GRP94 protein Biological characteristics Tumors Research progress
  • 相关文献

参考文献3

二级参考文献31

  • 1李海燕,王小平,陈瑞芬,刘国贞,宋爱利.人食管癌组织中热休克蛋白70和糖调节蛋白94的表达[J].首都医科大学学报,2004,25(2):183-185. 被引量:1
  • 2Marzec M, Eletto D, Argon Y. GRP94: an HSP90-like pro- tein specialized for protein folding and quality control in the endoplasmic reticulum [ J ]. Biochim Biophys Acta, 2012, 1823(3) : 774 -787.
  • 3Tachimori Y, Nagai Y, Kanamori N, et al. Pattern of lymph node metastases of esophageal squamous cell carcinoma based on the anatomical lymphatic drainage system [ J ]. Dis Esopha- gus, 2011, 24(1): 33-38.
  • 4Kim T, Grobmyer S R, Smith R, et al. Esophageal cancer the five year survivors[J]. J Surg Oncol, 2011, 103 (2) : 179 - 183.
  • 5Shin H R, Carlos M C, Varghese C. Cancer control in the A- sia Pacific region: current status and concerns[J]. Jpn J Clin Oncol, 2012, 42(10): 867-881.
  • 6Bharat A, Crabtree T. Management of advanced-stage oper- able esophageal cancer [J]. Surg Clin North Am, 2012, 92 (5): 1179-1197.
  • 7Planutiene M, Planutis K, Holcombe R F. Lymphoid enhan- cer-binding factor 1, a representative of vertebrate-specific Lefl/Tcfl sub-family, is a Wnt-beta-catenin pathway target gene in human endothelial cells which regulates matrix metal- loproteinase-2 expression and promotes endothelial cell inva- sion[J]. Vasc Cell, 2011, 3: 28.
  • 8Kwon M, Lee S J, Wang Y, et al. FilaminA interacting pro- tein l-like inhibits WNT signaling and MMP expression to suppress cancer cell invasion and metastasis [ J ]. Int J Canc- er, 2014, 135(1) : 48 -60.
  • 9Groblewska M, Siewko M, Mroczko B, et al. The role of ma- trix metalloproteinases (MMPs) and their inhibitors (TIMPs) in the developmem of esophageal cancer [ J ]~ Folia Histo- chem Cytobiol, 2012, 50(1) : 12- 19.
  • 10Merdad A, Karim S, Schulten H J, et al. Expression of ma- trix metalloproteinases (MMPs) in primary human breast cancer: MMP-9 as a potential biomarker for cancer invasion and metastasis[J]. Anticancer Res, 2014, 34(3) : 1355 - 1366.

共引文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部